NEW YORK (360Dx) – Chembio Diagnostics announced today that it has signed an agreement to commercialize its point-of-care tests for Dengue, Zika, and Chikungunya infection in Brazil with Bio-Manguinhos.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have an account?
Login Now.